欢迎来到天天文库
浏览记录
ID:55315260
大小:203.97 KB
页数:3页
时间:2020-05-14
《干扰素中和抗体的产生与难治性丙型肝炎的相关性.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、第36卷第4期兰州大学学报(医学版)VlO1.36No.42010年12月JournalofLanzhouUniversity(MedicalSciences)Dec.2010文章编号:1000—2812(2010)04-0073—03干扰素中和抗体的产生与难治性丙型肝炎的相关性张文杰,李朝霞,田淑菊,毛维武,龚晏萱,屈延f甘肃省第二人民医院感染科,甘肃摘要:目的探讨干扰素中和抗体fNA)的产生与难治性丙型肝炎的相关性。方法纳入102例初治慢性丙型肝炎患者,根据治疗效果分为难治性丙型肝炎组和对照组,用酶联免疫吸附法检测治疗前及治疗不同时期血清中的干扰素总抗体,同时应用抗病毒中和生物鉴
2、定法检测干扰素NA。结果44例难治性丙型肝炎患者中有l2例出现干扰素NA阳性,对照组干扰素NA的阳性率明显低于难治性丙型肝炎组fP3、ei—wu,GONGYan—xuail,QuYan{DepartmentofInfectiousDiseasesSecondPeople'sHospitalofGansuProvince}Lanzhou730000,China)Abstract:0bjectiveToevaluatetherelationshipbetweenanti·-interferonneutralizingantibod·。ies(NA)withrefractoryhepatitisC.Methods102caseswithchronichepatitisCweredividedintoreRactoryhe4、patitisCgroupandcontrolgroup.Thetotalanti—interferonQ—lbandNAweredetectedbyenzymeimmunlassayandantiviralneutralizingbioassayrespectivelyinseraof102caseswithchronichepatitisCbeforethetreatmentandindiferentperiodsduringthetreatmentwithinterferonOL—lborpegylationinterferon一2a.ResultsOfthe44re~acto5、rycaseswithhep—atitisC,12werepositiveforNA.ThepositiveratesofNAweresignificantlyhigherthanthatinthegroupofsustainedvirologicalresponse(P<0.05);therewasnostatisticdiferencebetweenthegroupwithinterferon一lbandthegroupwithpegylationinterferon一2a.ConclusionThedevelopmentofNAmaybeoneofthefactorsforre6、fractorypopulationinhepatitisC.Keywords:anti—interferonneutralizingantibodies;refractoryhepatitisC:chronichepatitisC收稿日期:2009—10—23作者简介:张文杰(1967___),男,安徽太和人,副主任医师,研究方向为病毒性肝病的诊治,e-mail:zhangwenjie718@163.tom。74兰州大学学报(医学版)第36卷难治性丙型肝炎是个较新的概念【1_,目前型肝炎病毒核糖核酸fhepatitisCvirusribonucleic将标准治疗后未获得持续病毒学应7、答者fsustainedacid,HCVRNA)载量水平,作为疗效观察指标。virologicalresponse,SVR)定义为难治性丙型肝炎,1.4疗效判定与分组而在抗病毒治疗过程中干扰素中和抗体(neutral—(1)SVR:即治疗结束至少随访24周时,定izingantibodies,NA)的产生亦会影响抗病毒治疗性检测HCVRNA阴性(或定量检测小于最低检的疗效。本研究以抗病毒生物中和法检测102例丙测限);(2)复发:指治疗结束时为定性检测HC
3、ei—wu,GONGYan—xuail,QuYan{DepartmentofInfectiousDiseasesSecondPeople'sHospitalofGansuProvince}Lanzhou730000,China)Abstract:0bjectiveToevaluatetherelationshipbetweenanti·-interferonneutralizingantibod·。ies(NA)withrefractoryhepatitisC.Methods102caseswithchronichepatitisCweredividedintoreRactoryhe
4、patitisCgroupandcontrolgroup.Thetotalanti—interferonQ—lbandNAweredetectedbyenzymeimmunlassayandantiviralneutralizingbioassayrespectivelyinseraof102caseswithchronichepatitisCbeforethetreatmentandindiferentperiodsduringthetreatmentwithinterferonOL—lborpegylationinterferon一2a.ResultsOfthe44re~acto
5、rycaseswithhep—atitisC,12werepositiveforNA.ThepositiveratesofNAweresignificantlyhigherthanthatinthegroupofsustainedvirologicalresponse(P<0.05);therewasnostatisticdiferencebetweenthegroupwithinterferon一lbandthegroupwithpegylationinterferon一2a.ConclusionThedevelopmentofNAmaybeoneofthefactorsforre
6、fractorypopulationinhepatitisC.Keywords:anti—interferonneutralizingantibodies;refractoryhepatitisC:chronichepatitisC收稿日期:2009—10—23作者简介:张文杰(1967___),男,安徽太和人,副主任医师,研究方向为病毒性肝病的诊治,e-mail:zhangwenjie718@163.tom。74兰州大学学报(医学版)第36卷难治性丙型肝炎是个较新的概念【1_,目前型肝炎病毒核糖核酸fhepatitisCvirusribonucleic将标准治疗后未获得持续病毒学应
7、答者fsustainedacid,HCVRNA)载量水平,作为疗效观察指标。virologicalresponse,SVR)定义为难治性丙型肝炎,1.4疗效判定与分组而在抗病毒治疗过程中干扰素中和抗体(neutral—(1)SVR:即治疗结束至少随访24周时,定izingantibodies,NA)的产生亦会影响抗病毒治疗性检测HCVRNA阴性(或定量检测小于最低检的疗效。本研究以抗病毒生物中和法检测102例丙测限);(2)复发:指治疗结束时为定性检测HC
此文档下载收益归作者所有